Specifically, GLUD1 is overexpressed in certain malignancies, such as non-small cell lung cancer (NSCLC) [90]; while it is downregulated in hepatocellular carcinoma (HCC) and clear cell renal carcinoma [91]. This evidence concerns the gene GLUD1 and non-small cell lung carcinoma.